Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (21 ops.)
Latest filing published 26 Nov 2025 for Merit Medical Systems INC, €764k.
Filing timeline
BuySaleFred P. Lampropoulos
Insider track record
Disclosed buys
0
Disclosed sells
21
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Fred P. Lampropoulos: trading record in brief
This profile gathers the share dealings of Fred P. Lampropoulos in Merit Medical Systems Inc, where the filings describe the role as chief executive. We count 59 filings; the first trade dates from 12 September 2016 and the latest from 25 November 2025.
Sales make up the whole of the open-market record (21 sales, €20.5M). Outside the open market, there are 24 share grants and 14 option exercises. Since January 2025: no purchases and 12 sales on the market.
Most recently, on 26 November 2025, the filings show an open-market sale worth €764k in Merit Medical Systems Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Fred P. Lampropoulos
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
10,000 shares@ US$88.03775.5% of flowCommon Stock, No Par ValueSEC:0000901534-25-000011:0
25,000 shares@ US$87.3114.5% of flowCommon Stock, No Par ValueSEC:0000901534-25-000009:0
20,000 shares@ US$85.132511.3% of flowCommon Stock, No Par ValueSEC:0000901534-25-000007:0
5,000 shares@ US$84.8263.8% of flowCommon Stock, No Par ValueSEC:0000901534-25-000005:0
159,151 shares@ US$55.7381.7% of flowCommon Stock, No Par ValueSEC:0001415889-25-023580:0
400 shares@ US$95.612.0% of flowCommon Stock, No Par ValueSEC:0001415889-25-017043:0
10,000 shares@ US$95.1949.9% of flowCommon Stock, No Par ValueSEC:0001415889-25-016204:0
10,000 shares@ US$95.12100.0% of flowCommon Stock, No Par ValueSEC:0001415889-25-015447:0
20,000 shares@ US$96.5418.5% of flowCommon Stock, No Par ValueSEC:0001415889-25-014805:0
11,320 shares@ US$104.0514.6% of flowCommon Stock, No Par ValueSEC:0001415889-25-007272:0
30,755 shares0Common Stock, No Par ValueSEC:0001415889-25-006309:0
24,572 shares0Common Stock, No Par ValueSEC:0001415889-24-006975:0
200,000 shares@ US$28.2068.8% of flowCommon Stock, No Par ValueSEC:0001415889-23-012784:0
5,278 shares@ US$67.6564.4% of flowCommon Stock, No Par ValueSEC:0001415889-23-005032:0
27,159 shares0Common Stock, No Par ValueSEC:0001415889-23-003930:0
50,000 shares@ US$16.0510.3% of flowCommon Stock, No Par ValueSEC:0001415889-22-008572:0
17,680 shares0Common Stock, No Par ValueSEC:0001415889-22-002081:0
5,000 shares@ US$17.270.8% of flowCommon Stock, No Par ValueSEC:0001415889-21-004349:0
18 of 18 declarations
